Synthesis of S-([18F]fluoromethyl)-(+)-McN5652 as a potential PET radioligand for the serotonin transporter.

[1]  O. Solin,et al.  Automated synthesis and purification of [18F]bromofluoromethane at high specific radioactivity. , 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[2]  Alan A. Wilson,et al.  Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.

[3]  Alexander Neumeister,et al.  [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder , 2000, Biological Psychiatry.

[4]  B. Bondy,et al.  Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide , 2000, Molecular Psychiatry.

[5]  F. Vollenweider,et al.  Efficient synthesis of enantiomerically pure thioester precursors of [11c]McN-5652 from racemic McN-5652 , 1999 .

[6]  M. Leboyer,et al.  Decreased serotonin transporter binding in unaffected relatives of manic depressive patients , 1999, Biological Psychiatry.

[7]  J. Barrio,et al.  Synthesis of 3β-(4-[18F]fluoromethylphenyl)- and 3β-(2-[18F] fluoromethylphenyl)tropane-2β-carboxylic acid methyl esters: new ligands for mapping brain dopamine transporter with positron emission tomography , 1999 .

[8]  J. Sandell,et al.  PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter. , 1999, Nuclear medicine and biology.

[9]  J. Sage,et al.  Depression and Anxiety in Parkinson's Disease: Possible Effect of Genetic Variation in the Serotonin Transporter , 1999, Journal of geriatric psychiatry and neurology.

[10]  P. Brust,et al.  Radioligands for the study of the 5-HT transporter in vivo. , 1999, IDrugs : the investigational drugs journal.

[11]  M. Reivich,et al.  Radiosynthesis and biodistribution of the S-[18F]fluoroethyl analog of McN5652. , 1996, Nuclear medicine and biology.

[12]  R. Dannals,et al.  An improved method for the synthesis of radiolabeled McN5652 via thioester precursors. , 1995, Nuclear medicine and biology.

[13]  Zsolt Szabo,et al.  Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652 , 1995, Synapse.

[14]  M. K. Das,et al.  Radiosynthesis of [F-18]fluoxetine as a potential radiotracer for serotonin reuptake sites , 1993 .

[15]  M. J. Costanzo,et al.  Determination of Enantiomeric Purity of Tertiary Amines by 1H NMR of α-Methoxy-α-(trifluoromethyl)phenylacetic Acid Complexes. , 1987 .

[16]  M. J. Costanzo,et al.  Determination of enantiomeric purity of tertiary amines by proton NMR of .alpha.-methoxy-.alpha.-(trifluoromethyl)phenylacetic acid complexes , 1986 .

[17]  H. Coenen,et al.  Preparation of N.C.A. [18F]-CH2BrF via aminopolyether supported nucleophilic substitution , 1986 .

[18]  O. Solin.  Counting of positron-emitting radionuclides on thin layer chromatograms , 1983 .

[19]  H N Wagner,et al.  A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  R. Myers,et al.  Citalopram: labelling with carbon-11 and evaluation in rat as a potential radioligand for in vivo PET studies of 5-HT re-uptake sites. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[21]  A. Wilson,et al.  Radiosynthesis and evaluation of N-(3-[18F]fluoropropyl)paroxetine as a radiotracer for in vivo labeling of serotonin uptake sites by PET. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[22]  V. Pike,et al.  The radiosynthesis of [N-methyl-11C]-sertraline. , 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[23]  D. Kuhl,et al.  Synthesis of radiolabeled inhibitors of presynaptic monoamine uptake systems; [18F]GBR 13119 (DA),[11C]nisoxetine (NE), and [11C]fluoxetine (5-HT) , 1989 .